Who has invested in Augustine Therapeutics?

Novo Holdings, Jeito Capital, Asabys Partners, Eli Lilly and Company, AdBio partners, V-Bio Ventures are named among the investors backing Augustine Therapeutics.

Augustine Therapeutics Funding: $104M Raised, Series A

Augustine Therapeutics funding overview

Augustine Therapeutics is based in Leuven, Belgium. Augustine Therapeutics has raised $104M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Augustine Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Novo Holdings, Jeito Capital, Asabys Partners, Eli Lilly and Company, AdBio partners, V-Bio Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.

Augustine Therapeutics at a glance

Total raised: $104M
Latest round: Series A
Latest round date: March 2025
Headquarters: Leuven, Belgium
Notable investors: Novo Holdings, Jeito Capital, Asabys Partners, Eli Lilly and Company, AdBio partners, V-Bio Ventures, PMV, VIB

Frequently asked about Augustine Therapeutics funding

How much has Augustine Therapeutics raised?: Augustine Therapeutics has raised $104M in total disclosed funding across the rounds on record.
Who has invested in Augustine Therapeutics?: Novo Holdings, Jeito Capital, Asabys Partners, Eli Lilly and Company, AdBio partners, V-Bio Ventures are named among the investors backing Augustine Therapeutics.
What was the latest Augustine Therapeutics funding round?: The most recent disclosed round is a Series A, announced in March 2025.
Where is Augustine Therapeutics based?: Augustine Therapeutics is based in Leuven, Belgium.
When did Augustine Therapeutics last raise?: The last disclosed Augustine Therapeutics round closed in March 2025 at Series A.

Augustine Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Leuven below to benchmark round size and investor mix.

Augustine Therapeutics Funding: $104M Raised, Series A

Augustine Therapeutics funding overview

Augustine Therapeutics at a glance

Frequently asked about Augustine Therapeutics funding

Companies related to Augustine Therapeutics (22)

Browse related funding lists (7)